Lataa...
Personalized medicine in metastatic non-small-cell lung cancer: promising targets and current clinical trials
Non-small-cell lung cancer (nsclc) remains the leading cause of cancer-related death globally, with most patients presenting with non-curable disease. Platinum-based doublet chemotherapy has been the cornerstone of treatment for patients with advanced-stage disease and has resulted in a modest incre...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Multimed Inc.
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3377759/ https://ncbi.nlm.nih.gov/pubmed/22787415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.1132 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|